Sun Pharmaceutical to Invest Rs 500 Crore in Assam Plant

Sun Pharmaceutical will establish a new manufacturing facility in the Indian state of Assam with an approximate investment of Rs 500 crore. The project is expected to create direct employment opportunities for over 500 people once the plant begins operations.

Senior officials from Sun Pharmaceutical met the chief secretary on Wednesday to discuss key aspects of rolling out the project. “Held a meeting with representatives of Sun Pharmaceutical Industries Limited... to review the company's proposal for setting up pharmaceutical manufacturing facilities in Assam,” Chief Secretary Ravi Kota said in an X post on Wednesday.

Also Read: Mass Spectrometry in Biomarker Discovery for Early Disease Detection

The company was represented by senior vice president Rahul Awasthi and associate vice president Ranjit Mohapatra during the meeting. According to Kota, “The proposal involves establishing drug formulation manufacturing units in the state to cater to the Indian market, with a planned investment of over Rs 500 crore to be implemented in two phases.”

The project will be executed in stages, with hiring also planned in phases. “The project is expected to generate direct employment for more than 500 people in a phased manner after commencement of operations,” the chief secretary said.

Several other factors were also discussed between government and private sector representatives including land needs, water availability, power availability, transport infrastructure and skilled labour/supply issues. The company also discussed their plans related to sustainable manufacturing which included water conservancy methods, renewable energy sources and responsible waste management procedures, all consistent with appropriate environmental regulations.

“The meeting was part of the Assam government's ongoing engagement with prospective investors to promote employment generation, inclusive development, and long-term economic growth in the state,” Kota added.